0001209191-19-005455.txt : 20190125
0001209191-19-005455.hdr.sgml : 20190125
20190125212752
ACCESSION NUMBER: 0001209191-19-005455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190124
FILED AS OF DATE: 20190125
DATE AS OF CHANGE: 20190125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIDA ANTHONY E III
CENTRAL INDEX KEY: 0001273213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 19543738
MAIL ADDRESS:
STREET 1: 157 TECHNOLOGY DR
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-24
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001273213
MAIDA ANTHONY E III
11500 S. EASTERN AVE.
SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock, $0.001 par value
2019-01-24
4
M
0
1550
3.92
A
34538
D
Common Stock, $0.001 par value
2019-01-24
4
S
0
1550
10.37
D
32988
D
Common Stock, $0.001 par value
2019-01-24
4
M
0
5700
5.05
A
38688
D
Common Stock, $0.001 par value
2019-01-24
4
S
0
5700
10.37
D
32988
D
Stock Option Exercise (Right to Buy)
3.92
2019-01-24
4
M
0
1550
0.00
D
2020-07-01
Common Stock
1550
0
D
Stock Option Exercise (Right to Buy)
5.05
2019-01-24
4
M
0
5700
0.00
D
2010-06-18
2020-04-20
Common Stock
5700
24300
D
All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010. The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013.
/s/ Kurt A. Gustafson, attorney-in-fact for Anthony E. Maida
2019-01-25